Streetbeat News

Price Targets

PAYX

Morgan Stanley analyst James Faucette has reiterated an Equal-Weight rating on Paychex (NASDAQ:PAYX) and maintained a $125 price target.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:07 pm

NKE

Morgan Stanley analyst Alex Kurtz has maintained an Overweight rating on Nike (NYSE:NKE) but lowered the price target from $130 to $127.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:06 pm

IFF

Morgan Stanley analyst Betsy Graseck has maintained an Overweight rating on Intl Flavors & Fragrances (IFF) but lowered the price target from $122 to $112.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:05 pm

ACCD

Morgan Stanley analyst Ricky Goldwasser has reiterated an Equal-Weight rating on Accolade (NASDAQ:ACCD) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:03 pm

AQST

JMP Securities analyst Jason Butler has reiterated a 'Market Outperform' rating on Aquestive Therapeutics (NASDAQ:AQST) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 1:00 pm

OPAD

JMP Securities analyst Nicholas Jones maintains a Market Outperform rating on Offerpad Solutions (NYSE:OPAD) and raises the price target from $11 to $14.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 12:59 pm

GHLD

JMP Securities analyst Trevor Cranston maintains a Market Outperform rating on Guild Holdings (NYSE:GHLD) but lowers the price target from $15 to $14.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 12:58 pm

MDT

CL King analyst Kristen Stewart has initiated coverage on Medtronic (NYSE:MDT) with a Buy rating and announced a price target of $106.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 12:56 pm

BSX

CL King analyst Kristen Stewart has initiated coverage on Boston Scientific (NYSE:BSX) with a Buy rating and a price target of $64.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 12:54 pm

INDI

Benchmark analyst Cody Acree has reiterated a 'Buy' rating on Indie Semiconductor (NASDAQ:INDI) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 12:50 pm